rs5745075

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006231.4(POLE):​c.6657+16C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.328 in 1,611,794 control chromosomes in the GnomAD database, including 91,794 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.35 ( 10024 hom., cov: 33)
Exomes 𝑓: 0.33 ( 81770 hom. )

Consequence

POLE
NM_006231.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -2.52

Publications

11 publications found
Variant links:
Genes affected
POLE (HGNC:9177): (DNA polymerase epsilon, catalytic subunit) This gene encodes the catalytic subunit of DNA polymerase epsilon. The enzyme is involved in DNA repair and chromosomal DNA replication. Mutations in this gene have been associated with colorectal cancer 12 and facial dysmorphism, immunodeficiency, livedo, and short stature. [provided by RefSeq, Sep 2013]
POLE Gene-Disease associations (from GenCC):
  • POLE-related polyposis and colorectal cancer syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • colorectal cancer, susceptibility to, 12
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • facial dysmorphism-immunodeficiency-livedo-short stature syndrome
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • IMAGe syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Polymerase proofreading-related adenomatous polyposis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 12-132625629-G-A is Benign according to our data. Variant chr12-132625629-G-A is described in ClinVar as Benign. ClinVar VariationId is 371835.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.674 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006231.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POLE
NM_006231.4
MANE Select
c.6657+16C>T
intron
N/ANP_006222.2Q07864

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POLE
ENST00000320574.10
TSL:1 MANE Select
c.6657+16C>T
intron
N/AENSP00000322570.5Q07864
POLE
ENST00000535270.5
TSL:1
c.6576+16C>T
intron
N/AENSP00000445753.1F5H1D6
POLE
ENST00000537064.5
TSL:1
n.*6408+16C>T
intron
N/AENSP00000442578.1F5H7E4

Frequencies

GnomAD3 genomes
AF:
0.353
AC:
53617
AN:
151992
Hom.:
10011
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.366
Gnomad AMI
AF:
0.262
Gnomad AMR
AF:
0.412
Gnomad ASJ
AF:
0.224
Gnomad EAS
AF:
0.693
Gnomad SAS
AF:
0.374
Gnomad FIN
AF:
0.407
Gnomad MID
AF:
0.332
Gnomad NFE
AF:
0.304
Gnomad OTH
AF:
0.342
GnomAD2 exomes
AF:
0.376
AC:
94000
AN:
249782
AF XY:
0.368
show subpopulations
Gnomad AFR exome
AF:
0.365
Gnomad AMR exome
AF:
0.489
Gnomad ASJ exome
AF:
0.233
Gnomad EAS exome
AF:
0.696
Gnomad FIN exome
AF:
0.401
Gnomad NFE exome
AF:
0.304
Gnomad OTH exome
AF:
0.334
GnomAD4 exome
AF:
0.325
AC:
475107
AN:
1459684
Hom.:
81770
Cov.:
36
AF XY:
0.327
AC XY:
237143
AN XY:
726222
show subpopulations
African (AFR)
AF:
0.360
AC:
12044
AN:
33470
American (AMR)
AF:
0.476
AC:
21283
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.230
AC:
6011
AN:
26106
East Asian (EAS)
AF:
0.693
AC:
27522
AN:
39698
South Asian (SAS)
AF:
0.372
AC:
32035
AN:
86224
European-Finnish (FIN)
AF:
0.391
AC:
20276
AN:
51816
Middle Eastern (MID)
AF:
0.339
AC:
1956
AN:
5766
European-Non Finnish (NFE)
AF:
0.301
AC:
334444
AN:
1111544
Other (OTH)
AF:
0.324
AC:
19536
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
16037
32073
48110
64146
80183
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11290
22580
33870
45160
56450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.353
AC:
53646
AN:
152110
Hom.:
10024
Cov.:
33
AF XY:
0.360
AC XY:
26786
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.365
AC:
15152
AN:
41510
American (AMR)
AF:
0.412
AC:
6301
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.224
AC:
778
AN:
3468
East Asian (EAS)
AF:
0.693
AC:
3579
AN:
5166
South Asian (SAS)
AF:
0.374
AC:
1797
AN:
4806
European-Finnish (FIN)
AF:
0.407
AC:
4306
AN:
10586
Middle Eastern (MID)
AF:
0.330
AC:
97
AN:
294
European-Non Finnish (NFE)
AF:
0.304
AC:
20671
AN:
67976
Other (OTH)
AF:
0.344
AC:
727
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1787
3574
5362
7149
8936
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
520
1040
1560
2080
2600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.314
Hom.:
1438
Bravo
AF:
0.356
Asia WGS
AF:
0.469
AC:
1626
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
4
not provided (4)
-
-
2
Colorectal cancer, susceptibility to, 12 (2)
-
-
1
Facial dysmorphism-immunodeficiency-livedo-short stature syndrome (1)
-
-
1
Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.15
DANN
Benign
0.47
PhyloP100
-2.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5745075; hg19: chr12-133202215; COSMIC: COSV57683709; COSMIC: COSV57683709; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.